Strategies and Techniques for Liver Magnetic Resonance Imaging: New and Pending Applications for Routine Clinical Practice

참고문헌

1. Tan CH, Chou SC, Inmutto N, Ma K, Sheng R, Shi Y, et al. Gadoxetate-enhanced MRI as a diagnostic tool in the management of hepatocellular carcinoma: report from a 2020 Asia-Pacific multidisciplinary expert meeting. Korean J Radiol 2022;23:697-719 
2. Thomaides-Brears HB, Lepe R, Banerjee R, Duncker C. Multiparametric MR mapping in clinical decision-making for diffuse liver disease. Abdom Radiol (NY) 2020;45:3507-3522 
3. Schulze J, Lenzen H, Hinrichs JB, Ringe B, Manns MP, Wacker F, et al. An imaging biomarker for assessing hepatic function in patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2019;17:192-199.e3 
4. Jiang H, Chen HC, Lafata KJ, Bashir MR. Week 4 liver fat reduction on MRI as an early predictor of treatment response in participants with nonalcoholic steatohepatitis. Radiology 2021;300:361-368 
5. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321 
6. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84 
7. Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 2018;67:123-133 
8. Hamilton G, Middleton MS, Bydder M, Yokoo T, Schwimmer JB, Kono Y, et al. Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging 2009;30:145-152 
9. Yoshizawa E, Yamada A. MRI-derived proton density fat fraction. J Med Ultrason (2001) 2021;48:497-506 
10. McDonald N, Eddowes PJ, Hodson J, Semple SIK, Davies NP, Kelly CJ, et al. Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study. Sci Rep 2018;8:9189 
11. Starekova J, Hernando D, Pickhardt PJ, Reeder SB. Quantification of liver fat content with CT and MRI: state of the art. Radiology 2021;301:250-262 
12. Gu Q, Cen L, Lai J, Zhang Z, Pan J, Zhao F, et al. A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease. Eur J Clin Invest 2021;51:e13446 
13. Yan J, Yao B, Kuang H, Yang X, Huang Q, Hong T, et al. Liraglutide, sitagliptin, and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease. Hepatology 2019;69:2414-2426 
14. Pooler BD, Wiens CN, McMillan A, Artz NS, Schlein A, Covarrubias Y, et al. Monitoring fatty liver disease with MRI following bariatric surgery: a prospective, dual-center study. Radiology 2019;290:682-690 
15. Satkunasingham J, Nik HH, Fischer S, Menezes R, Selzner N, Cattral M, et al. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors? Liver Transpl 2018;24:470-477 
16. Petitclerc L, Gilbert G, Nguyen BN, Tang A. Liver fibrosis quantification by magnetic resonance imaging. Top Magn Reson Imaging 2017;26:229-241 
17. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002;36:227-242 
18. Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 2015;13:440-451.e6 
19. Huwart L, Sempoux C, Vicaut E, Salameh N, Annet L, Danse E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008;135:32-40 
20. Zhan C, Kannengiesser S, Chandarana H, Fenchel M, Ream J, Shanbhogue KP. MR elastography of liver at 3 tesla: comparison of gradient-recalled echo (GRE) and spin-echo (SE) echo-planar imaging (EPI) sequences and agreement across stiffness measurements. Abdom Radiol (NY) 2019;44:1825-1833 
21. Kim DW, Kim SY, Yoon HM, Kim KW, Byun JH. Comparison of technical failure of MR elastography for measuring liver stiffness between gradient-recalled echo and spin-echo echo-planar imaging: a systematic review and meta-analysis. J Magn Reson Imaging 2020;51:1086-1102 
22. Kim SW, Lee JM, Park S, Joo I, Yoon JH, Chang W, et al. Diagnostic performance of spin-echo echo-planar imaging magnetic resonance elastography in 3T system for noninvasive assessment of hepatic fibrosis. Korean J Radiol 2022;23:180-188 
23. Yoon JW, Lee ES, Park HJ, Park SB, Cho YY, Kannengiesser S, et al. Comparison of spin-echo echo-planar imaging magnetic resonance elastography with gradient-recalled echo magnetic resonance elastography and their correlation with transient elastography. Diagn Interv Radiol 2022;28:294-300 
24. Shi Y, Qi YF, Lan GY, Wu Q, Ma B, Zhang XY, et al. Three-dimensional MR elastography depicts liver inflammation, fibrosis, and portal hypertension in chronic hepatitis B or C. Radiology 2021;301:154-162 
25. Morisaka H, Motosugi U, Glaser KJ, Ichikawa S, Ehman RL, Sano K, et al. Comparison of diagnostic accuracies of two- and three-dimensional MR elastography of the liver. J Magn Reson Imaging 2017;45:1163-1170 
26. Schaapman JJ, Tushuizen ME, Coenraad MJ, Lamb HJ. Multiparametric MRI in patients with nonalcoholic fatty liver disease. J Magn Reson Imaging 2021;53:1623-1631 
27. Huwart L, Peeters F, Sinkus R, Annet L, Salameh N, ter Beek LC, et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed 2006;19:173-179 
28. Asbach P, Klatt D, Schlosser B, Biermer M, Muche M, Rieger A, et al. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology 2010;257:80-86 
29. Klatt D, Hamhaber U, Asbach P, Braun J, Sack I. Noninvasive assessment of the rheological behavior of human organs using multifrequency MR elastography: a study of brain and liver viscoelasticity. Phys Med Biol 2007;52:7281-7294 
30. Yin M, Glaser KJ, Manduca A, Mounajjed T, Malhi H, Simonetto DA, et al. Distinguishing between hepatic inflammation and fibrosis with MR elastography. Radiology 2017;284:694-705 
31. Wang QB, Zhu H, Liu HL, Zhang B. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 2012;56:239-247 
32. Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, et al. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol 2016;26:1431-1440 
33. Guo Y, Parthasarathy S, Goyal P, McCarthy RJ, Larson AC, Miller FH. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging 2015;40:818-834 
34. Yoon JH, Lee JM, Joo I, Lee ES, Sohn JY, Jang SK, et al. Hepatic fibrosis: prospective comparison of MR elastography and US shear-wave elastography for evaluation. Radiology 2014;273:772-782 
35. Poetter-Lang S, Bastati N, Messner A, Kristic A, Herold A, Hodge JC, et al. Quantification of liver function using gadoxetic acid-enhanced MRI. Abdom Radiol (NY) 2020;45:3532-3544 
36. Bastati N, Beer L, Ba-Ssalamah A, Poetter-Lang S, Ambros R, Kristic A, et al. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD. J Hepatol 2022;77:1005-1013 
37. Bae KE, Kim SY, Lee SS, Kim KW, Won HJ, Shin YM, et al. Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis 2012;30:617-622 
38. Yoon JH, Lee JM, Paek M, Han JK, Choi BI. Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging. Eur Radiol 2016;26:1775-1782 
39. Yoon JH, Lee JM, Kim E, Okuaki T, Han JK. Quantitative liver function analysis: volumetric T1 mapping with fast multisection B1 inhomogeneity correction in hepatocyte-specific contrast-enhanced liver MR imaging. Radiology 2017;282:408-417 
40. Kim JE, Kim HO, Bae K, Choi DS, Nickel D. T1 mapping for liver function evaluation in gadoxetic acid-enhanced MR imaging: comparison of look-locker inversion recovery and B1 inhomogeneity-corrected variable flip angle method. Eur Radiol 2019;29:3584-3594 
41. Hinrichs H, Hinrichs JB, Gutberlet M, Lenzen H, Raatschen HJ, Wacker F, et al. Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC). Eur Radiol 2016;26:1116-1124 
42. Yoon JH, Lee JM, Kang HJ, Ahn SJ, Yang H, Kim E, et al. Quantitative assessment of liver function by using gadoxetic acid-enhanced MRI: hepatocyte uptake ratio. Radiology 2019;290:125-133 
43. Yoon JH, Choi JI, Jeong YY, Schenk A, Chen L, Laue H, et al. Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC. J Hepatol 2016;65:1155-1162 
44. Mozes FE, Tunnicliffe EM, Moolla A, Marjot T, Levick CK, Pavlides M, et al. Mapping tissue water T1 in the liver using the MOLLI T1 method in the presence of fat, iron and B0 inhomogeneity. NMR Biomed 2019;32:e4030 
45. Tunnicliffe EM, Banerjee R, Pavlides M, Neubauer S, Robson MD. A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recovery T1 (shMOLLI-T1) in the liver. J Magn Reson Imaging 2017;45:450-462 
46. Wang N, Cao T, Han F, Xie Y, Zhong X, Ma S, et al. Free-breathing multitasking multi-echo MRI for whole-liver water-specific T1, proton density fat fraction, and R2* quantification. Magn Reson Med 2022;87:120-137 
47. Fujita S, Sano K, Cruz G, Fukumura Y, Kawasaki H, Fukunaga I, et al. MR fingerprinting for liver tissue characterization: a histopathologic correlation study. Radiology 2023;306:150-159 
48. Jaubert O, Arrieta C, Cruz G, Bustin A, Schneider T, Georgiopoulos G, et al. Multi-parametric liver tissue characterization using MR fingerprinting: simultaneous T1, T2, T2*,T2*, and fat fraction mapping. Magn Reson Med 2020;84:2625-2635 
49. Dzyubak B, Li J, Chen J, Mara KC, Therneau TM, Venkatesh SK, et al. Automated analysis of multiparametric magnetic resonance imaging/magnetic resonance elastography exams for prediction of nonalcoholic steatohepatitis. J Magn Reson Imaging 2021;54:122-131 
50. Nowak S, Mesropyan N, Faron A, Block W, Reuter M, Attenberger UI, et al. Detection of liver cirrhosis in standard T2-weighted MRI using deep transfer learning. Eur Radiol 2021;31:8807-8815 
51. Park HJ, Yoon JS, Lee SS, Suk HI, Park B, Sung YS, et al. Deep learning-based assessment of functional liver capacity using gadoxetic acid-enhanced hepatobiliary phase MRI. Korean J Radiol 2022;23:720-731 
52. Alsaqal S, Hockings P, Ahlstrom H, Gummesson A, Hedstrom A, Hulthe J, et al. The combination of MR elastography and proton density fat fraction improves diagnosis of nonalcoholic steatohepatitis. J Magn Reson Imaging 2022;56:368-379 
53. Barahman M, Grunvald E, Prado PJ, Bussandri A, Henderson WC, Wolfson T, et al. Point-of-care magnetic resonance technology to measure liver fat: phantom and first-in-human pilot study. Magn Reson Med 2022;88:1794-1805 
54. Seitz K, Greis C, Schuler A, Bernatik T, Blank W, Dietrich CF, et al. Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study. Ultraschall Med 2011;32:598-603 
55. Kim JH, Yoon JH, Bae JS, Park S, Han S, Lee JM. Multiarterial phase acquisition in gadoxetic acid-enhanced liver MRI for the detection of hypervascular hepatocellular carcinoma in high-risk patients: comparison of compressed sensing versus view sharing techniques. Invest Radiol 2023;58:139-147 
56. Ginocchio LA, Smereka PN, Tong A, Prabhu V, Nickel D, Arberet S, et al. Accelerated T2-weighted MRI of the liver at 3 T using a single-shot technique with deep learning-based image reconstruction: impact on the image quality and lesion detection. Abdom Radiol (NY) 2023;48:282-290 
57. Han S, Lee JM, Kim SW, Park S, Nickel MD, Yoon JH. Evaluation of HASTE T2 weighted image with reduced echo time for detecting focal liver lesions in patients at risk of developing hepatocellular carcinoma. Eur J Radiol 2022;157:110588 
58. Bae SH, Hwang J, Hong SS, Lee EJ, Jeong J, Benkert T, et al. Clinical feasibility of accelerated diffusion weighted imaging of the abdomen with deep learning reconstruction: comparison with conventional diffusion weighted imaging. Eur J Radiol 2022;154:110428 
59. Brunsing RL, Fowler KJ, Yokoo T, Cunha GM, Sirlin CB, Marks RM. Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI. Hepatoma Res 2020;6:59 
60. Park HJ, Seo N, Kim SY. Current landscape and future perspectives of abbreviated MRI for hepatocellular carcinoma surveillance. Korean J Radiol 2022;23:598-614 
61. Cunha GM, Villela-Nogueira CA, Bergman A, Lobo Lopes FPP. Abbreviated mpMRI protocol for diffuse liver disease: a practical approach for evaluation and follow-up of NAFLD. Abdom Radiol (NY) 2018;43:2340-2350 
62. Ghorra C, Pommier R, Piveteau A, Rubbia-Brandt L, Vilgrain V, Terraz S, et al. The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases. Eur Radiol 2021;31:2451-2460 
63. Hayoz R, Vietti-Violi N, Duran R, Knebel JF, Ledoux JB, Dromain C. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor. Eur Radiol 2020;30:6593-6602 
64. Gupta P, Soundararajan R, Patel A, Kumar-M P, Sharma V, Kalra N. Abbreviated MRI for hepatocellular carcinoma screening: a systematic review and meta-analysis. J Hepatol 2021;75:108-119 
65. Kim DH, Choi SH, Shim JH, Kim SY, Lee SS, Byun JH, et al. Magnetic resonance imaging for surveillance of hepatocellular carcinoma: a systematic review and meta-analysis. Diagnostics (Basel) 2021;11:1665 
66. Bousabarah K, Letzen B, Tefera J, Savic L, Schobert I, Schlachter T, et al. Automated detection and delineation of hepatocellular carcinoma on multiphasic contrast-enhanced MRI using deep learning. Abdom Radiol (NY) 2021;46:216-225